The challenge of COVID-19 has rapidly changed medical management worldwide. The relatively small time from pandemic to vaccines regulatory approval triggered a race toward vaccines development. However, important questions regarding SARS-CoV-2 vaccines remain. A case of complete Vogt-Koyanagi-Harada (VKH) Syndrome that occurred 4 days following SARS-CoV-2 vaccination and another patient that developed VKH 14 days post COVID-19 clinical onset are presented. A causal relationship between COVID-19 and uveitis may exist.

CONCLUSION: DE success rates with vitrified oocytes are significantly better than those with NDE cycles and similar to those with fresh donor oocytes as reported by SART. DE programs should give serious consideration to establishing oocyte banks to improve flexibility and patient convenience.

No abstract

No abstract